chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot to the touch; initially had swelling on arm/ area where I received the vaccine is swollen again; Initially she had some swelling on her and redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), HYDROCHLOROTHIAZIDE, METFORMIN, LOSARTAN, PROGESTERONE and LIOTHYRONINE.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness). On 26-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch). At the time of the report, VACCINATION SITE WARMTH (hot to the touch) outcome was unknown and VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) had resolved with sequelae.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Patient also states she is taking an inhaler and a birth control pill, however medication name was not specified.  Patient also reported she received an allergy shot in the same arm on Thursday, 21JAN2021, but not in the same area as the vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Vaccination site pain
Clinical narrative: arm hurts a little bit more than usual; pain at the injection site; pain in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (arm hurts a little bit more than usual), VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pain (She has always had refractory pain on her left arm and shoulder. On the day of the vaccination the pain happened at the injection site.). Concomitant products included METFORMIN and LEVOTHYROXINE for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder). On 09-Jan-2021, the patient experienced PAIN (arm hurts a little bit more than usual). On 09-Jan-2021, VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, PAIN (arm hurts a little bit more than usual) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient also reported using Natural hormones concomitantly. No treatment medications were reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Dyspnoea, Eye irritation, Fatigue
Clinical narrative: Injection site was warm to touch; Arm was sore; Injection site Induration; Tired; Really high fever (101-102 F); Queasy; Injection site swelling; Chills; Headache; had some swelling on her arm and redness; Eyes were burning; Unbalanced; Experienced shortness of breath; This spontaneous case was reported by a nurse and describes the occurrence of EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch) and PAIN IN EXTREMITY (Arm was sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), PYREXIA (Really high fever (101-102 F)), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was warm to touch). On 23-Jan-2021, PYREXIA (Really high fever (101-102 F)) was resolving. At the time of the report, EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 101-102 (High) Degree F, had fever that lasted till 23Jan2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Patient used acetaminophen and ice packs to treat symptoms.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site induration, Injection site swelling, Nausea, Pain in extremity
Clinical narrative: Injection site was warm to touch; Arm was sore; Injection site Induration; Tired; Really high fever (101-102 F); Queasy; Injection site swelling; Chills; Headache; had some swelling on her arm and redness; Eyes were burning; Unbalanced; Experienced shortness of breath; This spontaneous case was reported by a nurse and describes the occurrence of EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch) and PAIN IN EXTREMITY (Arm was sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), PYREXIA (Really high fever (101-102 F)), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was warm to touch). On 23-Jan-2021, PYREXIA (Really high fever (101-102 F)) was resolving. At the time of the report, EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 101-102 (High) Degree F, had fever that lasted till 23Jan2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Patient used acetaminophen and ice packs to treat symptoms.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Injection site was warm to touch; Arm was sore; Injection site Induration; Tired; Really high fever (101-102 F); Queasy; Injection site swelling; Chills; Headache; had some swelling on her arm and redness; Eyes were burning; Unbalanced; Experienced shortness of breath; This spontaneous case was reported by a nurse and describes the occurrence of EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch) and PAIN IN EXTREMITY (Arm was sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), PYREXIA (Really high fever (101-102 F)), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was warm to touch). On 23-Jan-2021, PYREXIA (Really high fever (101-102 F)) was resolving. At the time of the report, EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 101-102 (High) Degree F, had fever that lasted till 23Jan2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Patient used acetaminophen and ice packs to treat symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Tenderness
Clinical narrative: saw two big , red areas , like two big spots , and are warm to touch; saw two big , red areas , like two big spots , and are warm to touch; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0131.20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On 29-Jan-2021, the patient experienced ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch). At the time of the report, TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Myalgia, SARS-CoV-2 test, Vision blurred
Clinical narrative: Positive for Covid-19; achiness; headache; blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vision), COVID-19 (Positive for Covid-19), MYALGIA (achiness) and HEADACHE (headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VISION BLURRED (blurred vision), MYALGIA (achiness) and HEADACHE (headache). On 25-Jan-2021, the patient experienced COVID-19 (Positive for Covid-19). The patient was treated with PARACETAMOL (TYLENOL) 22-Jan-2021 for Adverse event following immunisation, at a dose of UNK dosage form. At the time of the report, VISION BLURRED (blurred vision), COVID-19 (Positive for Covid-19), MYALGIA (achiness) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Rash pruritic
Clinical narrative: Little red spot on back, stomach; itching redspot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN, FINASTERIDE, LOSARTAN, SERTRALINE, TAMSULOSIN and VITAMINS NOS for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 20-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site reaction
Clinical narrative: local reaction at injection site; local reaction at injection site. It was a large, indurated area of redness; local reaction at injection site. It was a large, indurated area of redness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness). At the time of the report, VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives on hand,on legs,on torso,on buttocks; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing from 28-Jan-2021 for Hives, at a dose of 2 Tab as required. At the time of the report, URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia
Clinical narrative: headache; chills; got warm and thinks he has small fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included CLONIDINE and AMLODIPINE for Blood pressure management, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and ALPRAZOLAM for an unknown indication.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever). At the time of the report, HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever) outcome was unknown.            For treatment patient reported in middle of the night took migraine medicine, and today flu medicine (unspecified)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: Elevated Heart Rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated Heart Rate) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Elevated Heart Rate). At the time of the report, HEART RATE INCREASED (Elevated Heart Rate) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash erythematous, Sunburn, Tanning, Vaccination site pruritus
Clinical narrative: getting brown; felt like a hot sunburn almost like a hand size; itchy; started getting hot, red bumps on left arm where she got vaccine; pain, like sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain, like sore), RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine), SUNBURN (felt like a hot sunburn almost like a hand size), TANNING (getting brown) and VACCINATION SITE PRURITUS (itchy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (pain, like sore). On 24-Jan-2021, the patient experienced RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine) and VACCINATION SITE PRURITUS (itchy). On 25-Jan-2021, the patient experienced SUNBURN (felt like a hot sunburn almost like a hand size). On 27-Jan-2021, the patient experienced TANNING (getting brown). At the time of the report, PAIN (pain, like sore), RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine), SUNBURN (felt like a hot sunburn almost like a hand size), TANNING (getting brown) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: develops a numbness and tingling of the mouth and tongue immediately following the first dose; develops a numbness and tingling of the mouth and tongue immediately following the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Angioedema.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose). At the time of the report, HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. no treatment medications were reported. Per physician reporting the event, patient had history of angioedema with other medications, and developed reactions of numbness and tingling of mouth immediately following first dose.   This case was linked to MOD-2021-023363, MOD-2021-019227 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Neck pain
Clinical narrative: The back of her head is in a lot of pain; The neck is in a lot of pain; A spontaneous report was received from a consumer concerning a 30-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events back of her head is in a lot of pain, the neck is in a lot of pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) in the left arm for prophylaxis of COVID-19 infection.  On 24 Jan 2021, the patient experienced the event back of her head is in a lot of pain, the neck is in a lot of pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), back of her head is in a lot of pain was unknown.The outcome of event(s), the neck is in a lot of pain was unknown..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face
Clinical narrative: Swelling at facial filler injection site; Itching at facial filler injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Patients previous medical history included administration of Juvederm facial fillers in lips and cheek.     On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site). At the time of the report, SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported. No treatment medications were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Paraesthesia
Clinical narrative: tingling on and off; fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Bad history of migraine).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PARAESTHESIA (tingling on and off) and FATIGUE (fatigue). At the time of the report, PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Her physician reported , she was given epitome to prevent anaphylactic reaction.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pain in extremity
Clinical narrative: Arm Pain; Chills; Fever; Headache; Nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches). At the time of the report, PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Arm Pain; Chills; Fever; Headache; Nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches). At the time of the report, PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Headache, Myalgia
Clinical narrative: Headache; fever; Muscle pain; joint pain; chills; nausea; swollen injection site; whole arm hurt; cough; Pain when she touched injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE (SYNJARDY), LISINOPRIL, ATORVASTATIN and OMEPRAZOLE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain when she touched injection site pain). On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Vaccination site pain, Vaccination site swelling
Clinical narrative: Headache; fever; Muscle pain; joint pain; chills; nausea; swollen injection site; whole arm hurt; cough; Pain when she touched injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE (SYNJARDY), LISINOPRIL, ATORVASTATIN and OMEPRAZOLE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain when she touched injection site pain). On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itch at injection site; Rash and itch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site). At the time of the report, VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain in extremity
Clinical narrative: chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ROSUVASTATIN for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site reaction
Clinical narrative: injection site hardness; injection site redness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site hardness), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (injection site redness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site hardness) and VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, VACCINATION SITE REACTION (injection site hardness), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Red circle around the injection site and warm to the touch; A red circle around the injection site; A spontaneous report was received from a Consumer concerning a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events a red circle around the injection site, warm to the touch.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (Batch Number: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Jan 2021, the patient experienced the events of a red circle around the injection site and warm to the touch.  No treatment information was provided  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, a red circle around the injection site and warm to the touch was not reported..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm sores; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Arm sores) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm sores). The patient was treated with ALCOHOL (topical) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm sores) was resolving. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Outcome added as recovering. Consumer doesn't need further follow-up.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Lymphadenopathy, Pain, Tenderness
Clinical narrative: Pain in left arm for 36 hours; Diarrhea twice a morning every day; Tenderness at back of neck/base of neck/clavicle; Swollen lymph nodes on left side; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Mucocutaneous lymph node syndrome (at the age of 4 years).   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. On 15-Jan-2021, PAIN (Pain in left arm for 36 hours), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) had resolved. On 22-Jan-2021, DIARRHOEA (Diarrhea twice a morning every day) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient uses unspecified allergic concomitant medications.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia, Arthralgia, Chills, Cough, Fatigue
Clinical narrative: sneezed; lost her voice; cough; post nasal drainage; sinus headache; itchiness at the injection site; arm soreness; chills; really tired; achy all over; pain all over; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired) and PAIN (achy all over) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over) and PAIN (pain all over). On 27-Jan-2021, the patient experienced COUGH (cough), RHINORRHOEA (post nasal drainage) and SINUS HEADACHE (sinus headache). On 28-Jan-2021, the patient experienced APHONIA (lost her voice). On an unknown date, the patient experienced SNEEZING (sneezed). At the time of the report, INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over), PAIN (pain all over), COUGH (cough), RHINORRHOEA (post nasal drainage), SINUS HEADACHE (sinus headache), APHONIA (lost her voice) and SNEEZING (sneezed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. Treatment included Aleve   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No new information reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Pain, Rhinorrhoea, Sinus headache, Sneezing
Clinical narrative: sneezed; lost her voice; cough; post nasal drainage; sinus headache; itchiness at the injection site; arm soreness; chills; really tired; achy all over; pain all over; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired) and PAIN (achy all over) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over) and PAIN (pain all over). On 27-Jan-2021, the patient experienced COUGH (cough), RHINORRHOEA (post nasal drainage) and SINUS HEADACHE (sinus headache). On 28-Jan-2021, the patient experienced APHONIA (lost her voice). On an unknown date, the patient experienced SNEEZING (sneezed). At the time of the report, INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over), PAIN (pain all over), COUGH (cough), RHINORRHOEA (post nasal drainage), SINUS HEADACHE (sinus headache), APHONIA (lost her voice) and SNEEZING (sneezed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. Treatment included Aleve   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No new information reported.